Se trata de un ensayo con el que se pretende evaluar la capacidad de las células madre mesenquimales para mejorar la cicatrización de las heridas que por causa de la enfermedad aparecen en los afect...
Read moreTakeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced new data from the Phase 3 ADMIRE-CD clinical trial, ...
Read moreEl Hospital Universitario La Paz lidera un proyecto de investigación financiado por la Unión Europea en el programa H2020 que pretende confirmar el beneficio de la terapia con células madre en la c...
Read moreLa Comisión de Garantías para la Donación y Utilización de Células y Tejidos Humanos acaba de publicar la memoria de sus últimos cuatro años de actividad. Constituida en el año 2012, la Comisi...
Read moreEs el resultado principal de una tesis de la UEx que plantea estrategias alternativas para mejorar el efecto terapéutico de las células madre adultas
Read moreTiGenix NV (Euronext Brussels and Nasdaq: TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platform of allogeneic stem cell...
Read moreCon el aumento de la esperanza de vida de la población, se ha incrementado la prevalencia de heridas cutáneas agudas y crónicas que presentan problemas de cicatrización. Cirugías, laceraciones...
Read moreTiGenix NV (Euronext Brussels and Nasdaq: TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platform of allogeneic stem cell...
Read moreThese comprise a small group of passive stem cells—quiescent—that are activated when needed and have the capacity to produce any kind of intestinal cell. Quiescent cells are relevant for tissue re...
Read moreTiGenix NV (Euronext Brussels and Nasdaq: TIG), an advanced biopharmaceutical company focused on developing novel therapeutics from its two proprietary platforms of donor-derived expanded adipose deri...
Read moreThe study shows that using pluripotent stem cells derived from patients (iPSC) and animal models of the disease- the genes involved in the development of the stretchmark nucleus –the affected struct...
Read moreAs part of this agreement, studies will be carried out based on the use of cellular models from various types of tumours as well as the CNIO's platform of tumour stem cells. An important part of the s...
Read more